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Abstract
Background: Sinew acupuncture is a new modality of acupuncture in which needles are inserted into acupoints,
ashi points or spasm points of sinew and muscles along the meridian sinew pathway. A previous observational
study revealed that sinew acupuncture has immediate analgesic effects on various soft tissue injuries, including
knee injuries. However, no rigorous trials have been conducted. This study aims to examine whether sinew
acupuncture can safely relieve pain and symptoms of knee osteoarthritis (KOA) and improve patients’ functional
movement and quality of life.
Methods/design: A randomized, sham-controlled, patient- and assessor-blinded trial will be conducted to compare
the efficacy of sinew acupuncture and sham acupuncture. Subjects will be assessed by the physician and acupuncturists.
A sample of eighty-six eligible subjects will be randomized into either the sinew acupuncture group or the sham
acupuncture group. The intervention will be performed in the Hong Kong Tuberculosis Association Chinese Medicine
Clinic cum Training Centre of the University of Hong Kong by acupuncturists with over 3 years of acupuncture
experience. Subjects will receive 10 sessions of interventions for 4 weeks, followed by a 6-week follow-up. The
visual analogue scale (VAS) score at week 4 will be the primary outcome. The Western Ontario and McMasters
University Osteoarthritis Index (WOMAC), Timed Up & Go Test (TUG), 8-step Stair Climb Test (SCT) and the 36-Item
Short Form Survey (SF-36) will be secondary outcomes.
Discussion: Sinew acupuncture is a potential alternative non-pharmacological therapy for KOA. This rigorous trial
will expand our knowledge of whether sinew acupuncture reduces pain intensity and improves symptoms, functional
movements, and quality of life of KOA patients.
Trial registration: The study was registered at ClinicalTrials.gov (Identifier: NCT03099317) in March 2017.
Keywords: Sinew acupuncture, Sham acupuncture, Knee osteoarthritis, Pain, Randomized controlled trial, Protocol
Background
Osteoarthritis is one of the leading causes of disability in
the elderly worldwide [1, 2]. The knee is the most com-
monly affected site [3]. Hip and knee osteoarthritis was
ranked the 11th highest contributor to years lived with
disability globally [4]. A US population-based survey
found that 30.8% of men above the age of 65 and 34.8%
of elderly women have radiographic evidence of knee
osteoarthritis (KOA) [5, 6]. A survey study with the
same protocol conducted in China found that the preva-
lence of KOA in elderly men (27.6%) was similar, but the
prevalence in elderly women (46.6%) was higher than
that in the US study [6]. Furthermore, the two studies
revealed that the prevalence of pain in KOA was 6.9% to
7.1% in elderly men and 11.6% to 15.4% in elderly
women [6]. In 1997, the cost of osteoarthritis in the
USA, Canada, UK, France, and Australia accounted for
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up to 1–2.5% of the gross national product in each of
these countries [7]. Approximately one-third of direct
osteoarthritis expenditures were from medications,
mainly for pain-related agents [8]. The burden of osteo-
arthritis will continue to increase worldwide in the age-
ing population.
Knee pain largely affects KOA patients’ quality of life
and is the major reason patients seek medical help and
advice [9]. Many modalities of non-pharmacological,
pharmacological and surgical therapies have been imple-
mented to reduce pain in KOA patients, including
acupuncture, exercise, non-steroidal anti-inflammatory
drugs (NSAIDs), COX − 2 selective agents, and joint re-
placement surgery [10]. NSAIDs and COX-2 inhibitors
are commonly prescribed medications [10] but are asso-
ciated with an increased risk of gastrointestinal bleeding
and cardiovascular events [10].
Acupuncture has been widely used for KOA, although
large-scale randomized controlled trials have shown
contradictory results [11–14]. The discrepancies are
caused by various factors such as the characteristics of
controls [15, 16] and the dose of acupuncture treatment
[16]. Systematic reviews have indicated that acupuncture
is beneficial for patients with KOA [17, 18] and that the
effects of acupuncture last for over 12 months [19].
Sinew acupuncture, a specific modality of acupunc-
ture, was named by Professor Nongyu Liu. It was devel-
oped following the principles of Huangdi Neijing, a
classic Chinese medical text, in conjunction with clinical
experience [20–22]. Huangdi Neijing means “taking the
[points of] tenderness as acupoints”. Needles are
inserted superficially at sinew points (spasm points,
painful points, or acupoints close to or distal to the pain)
along the meridian sinew pathway to achieve therapeutic
effects [22, 23]. TCM treatments, based on the theory of
meridian sinews, have recently been used for pain man-
agement [24–27]. Sinew acupuncture potentially reduces
the risk of internal organ injuries. Sinew acupuncture
generally causes less pain than traditional acupuncture,
as it does not require deep insertion of needles or the
Deqi sensation by manual manipulation of the needle,
such as lifting, thrusting, twisting, and twirling [28].
Our previous observational studies have indicated that
sinew acupuncture has immediate analgesic effects on
soft tissue injuries at various locations (knee, elbow,
back, neck and shoulders) [29]. As no controls were
used in the previous observational studies, it is unclear
whether the immediate analgesic effects are due to true
effects or spontaneous remission of the tissue injury.
The proposed study aims to examine whether sinew
acupuncture can relieve pain and symptoms of KOA
and improve functional movement as measured by the
visual analogue scale (VAS), the Western Ontario and
McMasters University Osteoarthritis Index (WOMAC),
the Timed Up & Go Test (TUG) and the 8-Step Stair
Climb Test (SCT). We will also evaluate whether sinew
acupuncture can improve quality of life (QOL) as mea-
sured by the 36-Item Short Form Survey (SF-36).
Furthermore, we will evaluate the safety of sinew acu-
puncture in treating KOA. We hypothesized that sinew
acupuncture can safely relieve pain, enhance functional
movement and improve QOL in KOA patients com-
pared to sham acupuncture.
Methods/design
Study design
A randomized, sham-controlled, patient- and assessor-
blinded trial will be conducted to compare the efficacy of
sinew acupuncture and sham acupuncture. Subjects will
receive 10 sessions of interventions, either sinew acupunc-
ture or sham acupuncture, for 4 weeks followed by a 6-
week follow-up period. The interventions will be per-
formed by acupuncturists with more than 3 years of ex-
perience in acupuncture practice. Subjects will be blinded
to the intervention and assessed by independent assessors
using the primary outcome measure, VAS, and the sec-
ondary outcome measures, WOMAC, TUG and 8-step
SCT. The details of the study design are shown in Fig. 1.
Study subjects
Subjects will be recruited from the Hong Kong Tubercu-
losis Association Chinese Medicine Clinic cum Training
Centre of the University of Hong Kong, local nursing
homes and community centres using advertisements in
local newspapers. The eligibility of subjects will be
assessed by the physician and acupuncturists using the
criteria described below.
Inclusion criteria
Subjects are eligible to participate if they meet the fol-
lowing criteria: (i) are male or female Hong Kong per-
manent residents aged 50 years or above; (ii) meet the
Clinical Classification Criteria for Osteoarthritis of the
Knee as recommended by the American College of
Rheumatology, have knee pain, have radiologic findings
of osteoarthritis with Kellgren and Lawrence Grades
2–4, and have less than 30 min of morning stiffness or
crepitus on active motion and osteophytes as determined
by history and physical examination; (iii) have either
unilateral knee pain or bilateral knee pain; (iv) have ex-
perienced pain for at least 6 months and knee pain >
40 mm on a visual analogue scale (VAS; 0 to 100 mm)
within the past 7 days; and (v) are able to read and write
Chinese and sign the informed consent form.
Exclusion criteria
Subjects will be excluded if they meet any of the following
criteria: (i) are unable to walk; (ii) have a serious infection
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of the knee; (iii) have suspected tears in any ligaments or
menisci or acute inflammation of the synovial capsule; (iv)
have a history of trauma, ligament damage, fracture, or
surgery on the knee(s) within 6 months, causing pain or
functional problems (history of knee replacement will be
excluded); (v) have a history of local tumour/malignancy
at the knee; (vi) have physical or laboratory findings indi-
cating infection, presence of autoimmune disease or in-
flammatory arthritis; (vii) have knee pain caused by
radiculopathy/herniation of an intervertebral disc; (viii)
have end-stage diseases or other suspected severe condi-
tions such as deep vein thrombosis of the lower limb,
oedema related to cancer or cancer treatment, severe
blood coagulation disorders, uncontrolled systemic arterial
hypertension and severe diabetes; (ix) have a history of
prolotherapy, hyaluronic acid injections or corticosteroids
injections within 3 months; (x) have received acupuncture,
electro-acupuncture, Tui-na therapy, massage, or physio-
therapy 8 weeks prior to enrolment in the trial; (xi) have
severe pain in other regions; (xii) have severe mental
disorder(s); (xiii) are oversensitive to needles; and (xiv) are
insensitive to pain due to advanced diabetes, neuropathy
or use of strong painkillers.
Eligible subjects will receive baseline assessments and
will be randomly allocated to the sinew acupuncture
group (n = 43) or the sham acupuncture group (n = 43)
in a ratio of 1:1 by block randomization. The random
digits and letters will be generated by SPSS, covered by
aluminium foil, and sealed into opaque envelopes.
Subjects will be advised not to receive other acupunc-
ture treatments, Tui-na, massage or physiotherapy.
Subjects are not restricted from the use of painkillers
(including herbs) or external ointments if they suffer in-
tolerable pain. The use of rescue medications, the daily
level of morning stiffness and exercise time will be re-
corded in patient diaries.
Interventions
Sinew acupuncture group
Subjects receiving sinew acupuncture will sit on a chair
with the knee joint flexed at a most comfortable angle as
close to 90 degrees as possible (if required, a block of A4
papers will be placed under the foot to adjust the angle).
A hospital trolley table will be set up to block the vision of
the subject to his/her knee (for blinding purposes).
Routine disinfection will then be performed by the
Fig. 1 Flow diagram of the study protocol. Assessment measures will be performed as follows: (1) Pain: VAS (visual analogue scale) and WOMAC
(Western Ontario & McMasters University Osteoarthritis Index); (2) Functional movement: TUG (Timed up & Go Test) and 8-step SCT (Stair Climb Test);
(3) Quality of life: Short Form-36 (SF-36); (4) Credibility test (end of weeks 2 & 4); (5) Test of blinding success (end of week 4); (6) Patient diary (weekly)
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acupuncturist with a 75% alcohol pad. Acupoints (1–2 cm
away from the point of tenderness, spasm or pain) along
the meridian sinews near the knee(s) will be punctured
through the skin by using sterile needles with a size
of 0.30 mm× 40 mm (MOCM®) at an angle of 0–10 de-
grees pointing along the direction of the pain and the me-
ridian sinew. The needles will be withdrawn immediately to
a depth just under the skin and inserted forward smoothly
10 mm to 20 mm to avoid inducing pain. Five to eight
points will be selected on each painful knee (while walking
and climbing stairs) based on the theory of sinew acupunc-
ture. Adjustments of the needles will be performed by ex-
tension and flexion of the knee joint to ensure that the
needles do not cause pain during movement. Needles will
be covered immediately by hypoallergenic bandages. The
trolley table will be pulled away. Subjects will be advised to
walk for 10 min (including the needle adjustment time).
Needles will be adjusted at any time during walking if
the subject has any pain induced by the acupuncture
needle (for safety purposes) or primary pain of KOA
(for the purpose of enhancing treatment effect). The
trolley table will be used for blinding when the acu-
puncturist adjusts the needles. The acupuncturist will
record the details of every adjustment procedure. After
10 min of walking, patients will be advised to step up
and down from a step (~ 18 cm in height) for 12 rounds
per knee. The pain points will be examined, and needle
adjustments will be performed if necessary, followed by
a period of rest by sitting for 5 min. After treatment,
the needles will be removed while the subject is in a sit-
ting position with the trolley table in place for blinding.
Bandages will be applied in the same position for con-
tinuous blinding. The entire procedure will last 30 min
per session. Subjects will receive 10 sessions of inter-
ventions for 4 weeks, starting with thrice a week during
the first 2 weeks and then twice a week during the last
2 weeks. The above procedures will be performed by
the acupuncturist and blinded to subjects.
Sham acupuncture group
Subjects in the sham acupuncture group will undergo
the same procedures as those in the sinew acupuncture
group except that the non-insertion sham acupuncture
will be applied. Briefly, subjects will sit in a chair and
their vision of their knees will be blocked by the trolley
table. After disinfection, sterile needles with a size of 0.
30 mm × 40 mm (MOCM ®) will be used to slightly
puncture the acupoint without passing through the skin.
The needles will immediately be covered with non-
allergenic bandages to ensure sufficient blinding.
Outcome measures
The VAS at week 4 will be the primary outcome. The
WOMAC, TUG, 8-step SCT, and SF-36 scores will be the
secondary outcomes. The assessment schedule is shown
in Table 1. Independent assessors who are not involved in
acupuncture treatments will perform the VAS assessments
(asking subjects to indicate the pain intensity at the most
painful points during walking and ascending/descending a
step and overall). Acupuncturists will complete a “Physical
Examination and Treatment Form” including details of
the medical history, diagnosis and treatment procedures.
The acupuncturists will communicate with the subjects
using neutral language. The administration of analgesics,
external ointments and herbal medicines and the time of
daily exercises will be collected weekly from patient diaries
Table 1 The schedule of enrollment, interventions, and assessments
Items Enrollment Allocation (baseline) Interventions (± 2 days) Follow-up
Time points (week) -2 0 1 2 3 4 6 10
Treatment sessions (n) – – 1 2 3 4 5 6 7 8 9 10 – –
Eligibility screen ✓
Informed consent ✓
VAS ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
WOMAC ✓ ✓ ✓ ✓ ✓ ✓ ✓
SF-36 ✓ ✓ ✓
TUG ✓ ✓ ✓ ✓ ✓
8-step SCT ✓ ✓ ✓ ✓ ✓
PE & Tx ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Patient Diary ✓ ✓ ✓ ✓ ✓ ✓
Credibility Test ✓ ✓
Test of Blinding Success ✓
Adverse events ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
PE & Tx, Physical Examination and Treatment Form; SCT, stair climb test; SF-36, 36-item short form; TUG, timed up & go test; VAS, visual analog scale; WOMAC,
Western Ontario and McMasters University Osteoarthritis Index
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during the intervention period and at each visit during the
follow-up period.
Measurement instruments
The 0–100 mm VAS is used to measure pain intensity.
Subjects will indicate pain intensity on the VAS, with
0 mm representing no pain and 100 mm representing the
most intolerable pain. Pain intensity will be measured at
the most painful point during walking, the most painful
point during ascending and descending a step, and the
overall pain before and immediately after every treatment
session and at follow-up at week 6 and week 10.
The WOMAC (Hong Kong Cantonese Version) [10] will
be completed by subjects and will assess three domains:
pain (5 items), stiffness (2 items) and physical function (17
items). The WOMAC will be measured at baseline, every
week for the first 4 weeks, week 6 and week 10.
The SF-36 (Hong Kong Cantonese version) will be
used to assess general QOL. The QOL will be collected
by assessors at baseline, week 4 and week 10.
TUG and 8-step SCT will be evaluated by assessors at
baseline, every 2 weeks after the last treatment session,
and at week 6 and week 10.
Assessment of credibility
The Credibility of Treatment Rating Scale will be used to
assess the credibility of the acupuncture treatments after
the 6th treatment at week 2 and the last treatment at week
4. The 4-item scale is specifically designed to assess the
credibility of acupuncture. The following questions will be
asked to each subject by the assessors: (1) Do you believe
this treatment will reduce the pain you are suffering? (2)
Would you recommend this treatment to a friend or rela-
tive with the same problem? (3) Does the treatment seem
to be a logical one? (4) Do you believe this treatment could
be very effective in curing your knee osteoarthritis? [30].
Assessment of blinding success for acupuncture treatment
The blinding success of subjects will be evaluated by as-
sessors after the last treatment session at week 4.
Subjects in both groups will be asked the following ques-
tion: “When you volunteered for the trial, you were in-
formed that you had an equal chance of receiving sinew
acupuncture or sham acupuncture treatment. Which
acupuncture do you think you received?” Three options
will be provided to the subjects, sinew acupuncture,
sham acupuncture, and uncertain. Those who answered
either sinew acupuncture or sham acupuncture will be
asked to provide a reason for that assumption; the re-
sults will be recorded [12].
Adverse events/serious adverse events
Subjects will be encouraged to report adverse events at
each treatment session using the TESS-adverse event
form. For serious adverse events such as death, life
threatening events, significant or persistent disability/in-
capacity, hospitalization or prolongation of existing
hospitalization, the date, time, vital signs and reasons for
treatment assignment disclosure should be noted in the
Severe Adverse Event (SAE) Form, reported to the Insti-
tutional Review Board (IRB) and monitored within 48 h.
If there are medical concerns such that the treatment
protocol has to be revised due to safety, sudden serious
adverse events or ethical reasons, the revision must be
approved by the IRB before implementation. If a subject
withdraws from the study, the reasons for withdrawal
will be recorded.
Safety
Either sinew acupuncture or sham acupuncture will be
performed by registered acupuncturists in Hong Kong
who have at least 3 years of acupuncture experience.
Throughout the trial, acupuncturists will follow the
guideline from the Hong Kong Hospital Authority on
Safety in Acupuncture for Chinese Medicine Practi-
tioners (2nd amended version, 2016) including (1) pre-
vention of fainting and syncope during acupuncture; (2)
prevention of bleeding and bending or breaking of nee-
dles during acupuncture; and (3) prevention of perform-
ing acupuncture on the skin with local infections, ulcers,
scars, or tumour. All acupuncture procedures adopted in
our clinic (The Hong Kong Tuberculosis Association
Chinese Medicine Clinic cum Training Centre of the
University of Hong Kong) will follow (1) the introduc-
tion of the Notice for Patients Receiving Acupuncture
and Tui-na Treatment at their first visit and (2) imple-
mentation of needle counting before and after each
acupuncture session.
Adhesive bandages will consist of a flexible, non-
woven, low-adherence contact layer and a low-allergy,
acrylic adhesive backing layer, which will be used to
maintain the needle position during movement.
Potential risks and management
During the treatment, all acupoints will be located
around the knee joint(s), and the needle insertion will be
superficial/subcutaneous with standardized disinfection
procedures. This method has very low risks of infection,
pneumothorax or perforation of the viscera.
Small amounts of bleeding or bruising may occasionally
occur. In clinical experience, a small amount of bleeding
can be stopped by applying pressure with sterile cotton
swabs/balls. Bruises usually disappear within 2–3 days.
A step test is used to evaluate the subjects’ pain points
while ascending/descending steps. To avoid falls, the
step will be placed near a treatment bed, and a clinical
assistant will accompany the subject at all times. The
stairwell on the same floor of the hospital equipped with
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handles, bright lighting and anti-slip coating will be used
for SCT assessment. Assessors will accompany the sub-
jects during TUG and SCT assessments.
Ethics and dissemination
The ethical validity of the study has been assessed and
approved by the Institutional Review Board of The
University of Hong Kong/Hospital Authority Hong Kong
West Cluster (HKU/HA HKW IRB, approved number
UW 16–2007). The study was registered on Clinical-
Trials.gov (Identifier: NCT03099317). The clinical study
will be overseen by the HKU/HA HKW IRB. All subjects
will receive sufficient information about the trial and
must sign the informed consent form prior to enrol-
ment. Case repot forms (CRFs) and study files will be ar-
chived for 3 years after completion of the final report
and locked in a research cabinet. The Personal Data
(Privacy) Ordinance (CAP 486) will be followed strictly.
Sample size estimation
G-power was used for sample size determination. The
sample size was estimated by the VAS value with sinew
acupuncture for knee pain using data from our pilot study
[29]. The study observed 85 sessions of acupuncture
treatments on the knee. After acupuncture treatments,
the average VAS was reduced from 38.9 to 21.0 (change =
− 17.9) with a standard deviation = 10.7. We estimated
that the sham acupuncture (17.9*60% = 10.74) could re-
duce 60% of pain intensity compared to true acupuncture.
The effect size was 0.673. With α = 0.05 and power (1-β)
=0.8, the sample size was determined to be 37 per group.
With the consideration of a 15% dropout rate, 86 subjects
are required in each of the two groups.
Data analysis
All data will be doubly entered into a password-protected
computer 1 week after data collection. The statistical ana-
lysis will be performed by SPSS 22.0 for Windows by a
single statistician. The scores will be analysed by the
intent-to-treat analysis. The last observation carried for-
ward method will be used for missing data. Comparisons
of continuous variables between the acupuncture and
sham groups will be assessed using Student’s t-test or ana-
lysis of covariance (ANCOVA) with baseline measures as
covariates. Comparisons of categorical data between
groups will be tested by the χ2 test or the Mann–Whitney
U-test. Changes in the scores from baseline within treat-
ment groups will be assessed by the paired t-test or the
Wilcoxon signed ranks test. Data from the patient diary
will be assessed to analyse covariate balances in the two
groups. If we find an imbalance, we will use the propensity
score method [31] or the conditional inference method
[32] to remove the confounding effect. All statistical tests
will be two-sided at a 5% significance level.
Discussion
KOA is one of the most common diseases among the
elderly. This study will evaluate the efficacy of sinew
acupuncture for pain reduction, functional movement
improvement, and QOL improvement in KOA patients.
In our clinic, there are 8–10 new KOA patients each
month. We estimate that recruitment will be completed
in 10 months.
The study is conducted in collaboration with the
School of Chinese Medicine, Department of Diagnostic
Radiology and Department of Orthopaedics & Trauma-
tology, Li Ka Shing Faculty of Medicine, HKU. The eligi-
bility of KOA subjects will be assessed by clinical
physicians. The intervention will be performed by expe-
rienced acupuncturists. The subjects and assessors will
be blinded to subjects’ allocations. The acupuncturist
will not be involved in assessments or data entry. Data
will be analysed by an independent statistician.
In acupuncture RCTs, it is critical to choose an appro-
priate control population. Vickers AJ et al. found that
acupuncture was superior to both sham and no acu-
puncture controls for osteoarthritis pain with effect sizes
of 0.16 and 0.57, respectively [18]. The small effect size
in trials with sham acupuncture controls may be due to
the following reasons: (1) the meta-analysis excluded
outlying studies showing a very large effect size [18] and
(2) according to Macpherson H, Vickers AJ, et al. in the
same research group, acupuncture has a smaller effect
size in trials with needle-insertion sham controls than in
trials with needle non-insertion sham or non-sham con-
trols [15]. Our previous study was consistent with their
findings that acupuncture trials with needle non-
insertion controls lead to more positive conclusions than
those with needle-insertion sham controls [16]. In the
present study, we will use needle non-insertion as the
control, which may produce a smaller, nonspecific effect
compared to needle-insertion sham controls. However, it
should be noted that the effect size estimated from our
pilot study [29] is larger than that of the previous study
by Vickers AJ et al. [18]. If the power estimates prove to
be high, the trail can be used to determine a more accur-
ate effect size for future power calculations.
This trial will expand our knowledge of whether sinew
acupuncture will reduce pain intensity, improve the symp-
toms and movements of KOA patients, and improve QOL.
If this study is successful, the effectiveness of sinew acu-
puncture may be studied using a pragmatic trial design.
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